Central Diabetes Insipidus (DI)/Arginine Vasopressin Deficiency (AVP-D) Clinical Pathway – PICU
Central Diabetes Insipidus (DI)/Arginine Vasopressin Deficiency (AVP-D) Clinical Pathway – PICU
Goals
- Minimize time with sodium out of range and risk of dehydration
Metrics
- Time from start of vasopressin to time of max dose
- # patients with hyponatremia (Na < 135) during vasopressin administration
- Duration of hyponatremia (Na < 135) during vasopressin administration
- Duration of hypernatremia (Na > 150) during vasopressin administration
- Time from start of vasopressin to time of 1st Na result ≤ 150